Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.36 |
| ▸ | ARG1 | P05089 | 1/20 | 0.35 |
| ▸ | ARG2 | P78540 | 1/20 | 0.35 |
| ▸ | GGT1 | P19440 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | FYN | P06241 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11408094 | 0.86 | ALDH1A1 (0.37) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL6882712 | 0.86 | MEN1 (0.46) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL7320060 | 0.79 | MEN1 (0.41) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL18036525 | 0.79 | MEN1 (0.41) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL1005537 | 0.79 | SMN1; SMN2 (0.37) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL31296136 | 0.79 | SMN1; SMN2 (0.37) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL766735 | 0.77 | SMN1; SMN2 (0.35) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL22612007 | 0.77 | HIF1A (0.44) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL22612005 | 0.77 | ALDH1A1 (0.40) | ALDH1A1MEN1CYP1A2KMT2ATHRB | |
| SCHEMBL16568741 | 0.77 | MEN1 (0.40) | ALDH1A1MEN1CYP1A2KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021106107-A1 | MATERIAL AND COLUMN FOR COLLECTING CELLS HAVING RECOVERY FUNCTION OF HYPO-IMMUNE STATE | 国立大学法人滋賀医科大学 | 2021-06-03 | — | — | WO | disclosed |
| CN-108349911-A | Releasable nitric oxide production prodrugs | 浙江华海药业股份有限公司 | 2018-07-31 | — | — | CN | disclosed |
| CN-104531794-B | A kind of preparation method of the aminobutyric acid esters of N BOC D 2 | 浙江工业大学 | 2017-07-28 | — | — | CN | disclosed |
| EP-2697373-A1 | PRODUCTION OF ENANTIOMERICALLY PURIFIED AMINO ACIDS | Dr. Reddy's Laboratories (EU) Limited (GB) | 2014-02-19 | — | — | EP | disclosed |
| WO-2012140507-A1 | PRODUCTION OF ENANTIOMERICALLY PURIFIED AMINO ACIDS | DR. REDDY'S LABORATORIES (EU) LIMITED (GB) | 2012-10-18 | — | — | WO | disclosed |
| US-6573263-B2 | For improving perception, concentration power, learning power and/ or memory power | BAYER AKTIENGESELLSCHAFT (DE) | 2003-06-03 | — | — | US | disclosed |
| US-20020198377-A1 | Substituted imidazotriazinones | BAYER AKTIENGESELLSCHAFT (DE) | 2002-12-26 | — | — | US | disclosed |
| CN-1284086-A | Conjugates useful in treatment of prostate cancer | MERCK & CO INC (US) | 2001-02-14 | — | — | CN | disclosed |
| US-4595532-A | N-(substituted-methyl)-azetidin-2-ones | UNIVERSITY OF NOTRE DAME DU LAC (US) | 1986-06-17 | — | — | US | disclosed |
| EP-0116432-A2 | Improvements in or relating to N-(substituted-methyl)-azetidin-2-ones | THE UNIVERSITY OF NOTRE DAME DU LAC (US) | 1984-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020198377-A1 | Substituted imidazotriazinones | CAMK4, ITPR1, KCNJ5 | ALDH1A1 3498/4885MEN1 2751/4885CYP1A2 2007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.